Odyssey Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Go back to Odyssey Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update| (NASDAQ: ODTX) | Delayed: 20.51 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $20.51 | 52 Week High | $ | |||
| Open | $20.51 | 52 Week Low | $ | |||
| Day High | $20.51 | P/E | N/A | |||
| Day Low | $20.51 | EPS | $ | |||
| Volume | 8 | |||||

